Enochian BioSciences surges on advancing potential HIV treatment

Lunai Bioworks

08/06/2020 17:04

** Shares of drug developer  ENOB.O  jump ~84% to $7.60
    ** Co says it successfully completed meeting with U.S. FDA
regarding its HIV treatment, ENOB-HV-01  urn:newsml:reuters.com:*:nGNX6VSMp2
    ** FDA feedback very much aligned with our development plan
- ENOB
    ** Co says ENOB-HV-01 has potential to cure HIV by
increasing chances that gene-modified cells resistant to HIV
infection, received via transplant, grow and begin to make new
cells
    ** Plans to file for clinical trial approval in 2021
    ** ENOB shares up ~51% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))